SciClone Pharmaceuticals, Inc. Announces ZADAXIN and SCV-07 Abstracts Accepted at American Society of Clinical Oncology

SAN MATEO, CA -- (MARKET WIRE) -- April 27, 2007 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the following abstracts have been accepted for the Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois on June 1-5, 2007:
MORE ON THIS TOPIC